Wells Fargo & Company »

Cadrenal Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 99 13.83
2025-06-30 $1.2k 100 12.05
2025-03-31 $1.8k 100 17.63

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Cadrenal Therapeutics

Vanguard Group
Citadel Advisors
LPL Financial
Geode Capital Management
Jpmorgan Chase & Co
BlackRock
Advisor Group Holdings
Morgan Stanley
Rockefeller Capital Management
Jones Financial Companies, L.L
Hartland & Co
Harbour Investments
Wells Fargo & Company
UBS Group
Archer Investment Corp

View all funds holding Cadrenal Therapeutics